Index of Severity for Eosinophilic Esophagitis (I-SEE)

The Index of Severity for Eosinophilic Esophagitis (I‑SEE) is a consensus clinical tool that scores symptoms, complications, and inflammatory and fibrostenotic features to classify EoE as mild, moderate, or severe.

Symptoms
None0Weekly+1Daily+2Multiple times per day disrupting social functioning+4
Food impaction
None0Food impaction with ER visit or endoscopy (pt ≥ 18 years)+2Food impaction with ER visit or endoscopy (pt < 18 years)+4
Hospitalization due to EoE
No0Yes+4
Esophageal perforation
No0Yes+15
Malnutrition
None0Malnutrition with body mass < 5th percentile or decreased growth trajectory+15
Inflammation
None0Persistent inflammation requiring elemental formula, or systemic corticosteroid, or immunomodulatory treatments+15
Edema, furrows and/or exudates
None0Localized+1Diffuse+2
Eosinophil count
< 15 eos/hpf015-60 eos/hpf+1> 60 eos/hpf+2
Rings, strictures
None0Present, but endoscope passes easily+1Present, but requires dilation or a snug fit when passing a standard endoscope+2Cannot pass standard upper endoscope; repeated dilations (in an adult ≥ 18 years); or any dilation (in a child < 18 years)+15
BZH or LPF (or DEC/SEA if no LP)
No0Yes+2

Indikationen

Used for classifying EoE severity during routine visits to guide treatment intensity and follow‑up, based on symptoms/complications plus inflammatory and fibrostenotic endoscopic/histologic features (0–6 mild, 7–14 moderate, ≥15 severe) 1 [Level III evidence]. Provides prognostic information and helps predict response to topical steroids and biologics 2 [Level II evidence]; 3 [Level II evidence].

Hinweise & Vorsichtsmaßnahmen

Stratifies severity by symptoms/complications plus inflammatory and fibrostenotic features (scores 0–6 mild, 7–14 moderate, ≥15 severe) 1 [Level III evidence]. Prognostic utility is supported by correlations with molecular activity in nonsevere disease 2 [Level III evidence] and poorer steroid response in severe categories 3 [Level II evidence]. Not yet fully validated; symptoms may misrepresent biologic activity.